These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
292 related items for PubMed ID: 22180496
1. Monofunctional platinum-DNA adducts are strong inhibitors of transcription and substrates for nucleotide excision repair in live mammalian cells. Zhu G, Myint M, Ang WH, Song L, Lippard SJ. Cancer Res; 2012 Feb 01; 72(3):790-800. PubMed ID: 22180496 [Abstract] [Full Text] [Related]
2. Transcription inhibition by platinum-DNA cross-links in live mammalian cells. Ang WH, Myint M, Lippard SJ. J Am Chem Soc; 2010 Jun 02; 132(21):7429-35. PubMed ID: 20443565 [Abstract] [Full Text] [Related]
3. cis-Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects. Lovejoy KS, Todd RC, Zhang S, McCormick MS, D'Aquino JA, Reardon JT, Sancar A, Giacomini KM, Lippard SJ. Proc Natl Acad Sci U S A; 2008 Jul 01; 105(26):8902-7. PubMed ID: 18579768 [Abstract] [Full Text] [Related]
5. Spectrum of cellular responses to pyriplatin, a monofunctional cationic antineoplastic platinum(II) compound, in human cancer cells. Lovejoy KS, Serova M, Bieche I, Emami S, D'Incalci M, Broggini M, Erba E, Gespach C, Cvitkovic E, Faivre S, Raymond E, Lippard SJ. Mol Cancer Ther; 2011 Sep 27; 10(9):1709-19. PubMed ID: 21750216 [Abstract] [Full Text] [Related]
6. Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile. Park GY, Wilson JJ, Song Y, Lippard SJ. Proc Natl Acad Sci U S A; 2012 Jul 24; 109(30):11987-92. PubMed ID: 22773807 [Abstract] [Full Text] [Related]
7. Replacement of a thiourea with an amidine group in a monofunctional platinum-acridine antitumor agent. Effect on DNA interactions, DNA adduct recognition and repair. Kostrhunova H, Malina J, Pickard AJ, Stepankova J, Vojtiskova M, Kasparkova J, Muchova T, Rohlfing ML, Bierbach U, Brabec V. Mol Pharm; 2011 Oct 03; 8(5):1941-54. PubMed ID: 21806015 [Abstract] [Full Text] [Related]
8. X-ray structure and mechanism of RNA polymerase II stalled at an antineoplastic monofunctional platinum-DNA adduct. Wang D, Zhu G, Huang X, Lippard SJ. Proc Natl Acad Sci U S A; 2010 May 25; 107(21):9584-9. PubMed ID: 20448203 [Abstract] [Full Text] [Related]
9. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts. Kasparkova J, Novakova O, Farrell N, Brabec V. Biochemistry; 2003 Jan 28; 42(3):792-800. PubMed ID: 12534292 [Abstract] [Full Text] [Related]
10. The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adducts. Vaisman A, Varchenko M, Umar A, Kunkel TA, Risinger JI, Barrett JC, Hamilton TC, Chaney SG. Cancer Res; 1998 Aug 15; 58(16):3579-85. PubMed ID: 9721864 [Abstract] [Full Text] [Related]
11. Energetics, conformation, and recognition of DNA duplexes containing a major adduct of an anticancer azolato-bridged dinuclear Pt(II) complex. Mlcouskova J, Malina J, Novohradsky V, Kasparkova J, Komeda S, Brabec V. Biochim Biophys Acta; 2012 Oct 15; 1820(10):1502-11. PubMed ID: 22683702 [Abstract] [Full Text] [Related]
12. Anti-cancer characteristics and ototoxicity of platinum(II) amine complexes with only one leaving ligand. Monroe JD, Hruska HL, Ruggles HK, Williams KM, Smith ME. PLoS One; 2018 Oct 15; 13(3):e0192505. PubMed ID: 29513752 [Abstract] [Full Text] [Related]
13. Effect of a monofunctional phenanthriplatin-DNA adduct on RNA polymerase II transcriptional fidelity and translesion synthesis. Kellinger MW, Park GY, Chong J, Lippard SJ, Wang D. J Am Chem Soc; 2013 Sep 04; 135(35):13054-61. PubMed ID: 23927577 [Abstract] [Full Text] [Related]
14. Spontaneous translocation of antitumor oxaliplatin, its enantiomeric analogue, and Cisplatin from one strand to another in double-helical DNA. Malina J, Natile G, Brabec V. Chemistry; 2013 Sep 02; 19(36):11984-91. PubMed ID: 23873652 [Abstract] [Full Text] [Related]
15. Multiple states of stalled T7 RNA polymerase at DNA lesions generated by platinum anticancer agents. Jung Y, Lippard SJ. J Biol Chem; 2003 Dec 26; 278(52):52084-92. PubMed ID: 14534300 [Abstract] [Full Text] [Related]
16. Specificity of platinum-DNA adduct repair. Chaney SG, Vaisman A. J Inorg Biochem; 1999 Oct 26; 77(1-2):71-81. PubMed ID: 10626357 [Abstract] [Full Text] [Related]
17. The role of DNA polymerase eta in translesion synthesis past platinum-DNA adducts in human fibroblasts. Bassett E, King NM, Bryant MF, Hector S, Pendyala L, Chaney SG, Cordeiro-Stone M. Cancer Res; 2004 Sep 15; 64(18):6469-75. PubMed ID: 15374956 [Abstract] [Full Text] [Related]
18. Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells. Nehmé A, Baskaran R, Nebel S, Fink D, Howell SB, Wang JY, Christen RD. Br J Cancer; 1999 Mar 15; 79(7-8):1104-10. PubMed ID: 10098743 [Abstract] [Full Text] [Related]
20. PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs. Olaussen KA, Adam J, Vanhecke E, Vielh P, Pirker R, Friboulet L, Popper H, Robin A, Commo F, Thomale J, Kayitalire L, Filipits M, Le Chevalier T, André F, Brambilla E, Soria JC. Lung Cancer; 2013 May 11; 80(2):216-22. PubMed ID: 23410825 [Abstract] [Full Text] [Related] Page: [Next] [New Search]